207 related articles for article (PubMed ID: 18436738)
1. Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.
Kujawski L; Ouillette P; Erba H; Saddler C; Jakubowiak A; Kaminski M; Shedden K; Malek SN
Blood; 2008 Sep; 112(5):1993-2003. PubMed ID: 18436738
[TBL] [Abstract][Full Text] [Related]
2. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
[TBL] [Abstract][Full Text] [Related]
3. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.
Buhl AM; Jurlander J; Geisler CH; Pedersen LB; Andersen MK; Josefsson P; Petersen JH; Leffers H
Eur J Haematol; 2006 Jun; 76(6):455-64. PubMed ID: 16529606
[TBL] [Abstract][Full Text] [Related]
4. TOSO is overexpressed and correlated with disease progression in Chinese patients with chronic lymphocytic leukemia.
Yi S; Yu Z; Zhou K; Wang Y; An G; Li Z; Zou D; Qi J; Zhao Y; Chan WC; Qiu L
Leuk Lymphoma; 2011 Jan; 52(1):72-8. PubMed ID: 21133733
[TBL] [Abstract][Full Text] [Related]
5. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.
Rassenti LZ; Jain S; Keating MJ; Wierda WG; Grever MR; Byrd JC; Kay NE; Brown JR; Gribben JG; Neuberg DS; He F; Greaves AW; Rai KR; Kipps TJ
Blood; 2008 Sep; 112(5):1923-30. PubMed ID: 18577710
[TBL] [Abstract][Full Text] [Related]
6. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
[TBL] [Abstract][Full Text] [Related]
7. Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.
Ouillette P; Collins R; Shakhan S; Li J; Peres E; Kujawski L; Talpaz M; Kaminski M; Li C; Shedden K; Malek SN
Blood; 2011 Sep; 118(11):3051-61. PubMed ID: 21795749
[TBL] [Abstract][Full Text] [Related]
8. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
[TBL] [Abstract][Full Text] [Related]
9. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.
Li FJ; Ding S; Pan J; Shakhmatov MA; Kashentseva E; Wu J; Li Y; Soong SJ; Chiorazzi N; Davis RS
Blood; 2008 Jul; 112(1):179-87. PubMed ID: 18314442
[TBL] [Abstract][Full Text] [Related]
10. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population.
Dong HJ; Miao KR; Qiao C; Zhuang Y; Shen WY; Hong M; Fan L; Liu P; Xu W; Li JY
Leuk Lymphoma; 2011 Jun; 52(6):1003-9. PubMed ID: 21463115
[TBL] [Abstract][Full Text] [Related]
12. Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients.
Briani C; Visentin A; Salvalaggio A; Imbergamo S; Piazza F; Cacciavillani M; Campagnolo M; Frezzato F; Semenzato G; Trentin L
Haematologica; 2017 Apr; 102(4):e140-e143. PubMed ID: 27927770
[No Abstract] [Full Text] [Related]
13. Richter transformation in 16 of 149 Chinese patients with chronic lymphocytic leukemia.
Fan L; Wang L; Zhang R; Fang C; Zhu DX; Wang YH; Zou ZJ; Li JY; Xu W
Leuk Lymphoma; 2012 Sep; 53(9):1749-56. PubMed ID: 22329349
[TBL] [Abstract][Full Text] [Related]
14. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP
Cancer; 2008 Mar; 112(6):1296-305. PubMed ID: 18246537
[TBL] [Abstract][Full Text] [Related]
15. Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.
Rampazzo E; Bonaldi L; Trentin L; Visco C; Keppel S; Giunco S; Frezzato F; Facco M; Novella E; Giaretta I; Del Bianco P; Semenzato G; De Rossi A
Haematologica; 2012 Jan; 97(1):56-63. PubMed ID: 21933855
[TBL] [Abstract][Full Text] [Related]
16. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
[TBL] [Abstract][Full Text] [Related]
17. Unexpectedly high frequency of European parentage in Venezuelan patients with chronic lymphocytic leukemia.
Marquez ME; Deglesne PA; Lopez JL; Da Costa O; Borrego M; Hernández M; Muller A; Ajchenbaum-Cymbalista F; Romano E
Leuk Lymphoma; 2012 Feb; 53(2):235-41. PubMed ID: 21867460
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors.
Oscier DG; Gardiner AC; Mould SJ; Glide S; Davis ZA; Ibbotson RE; Corcoran MM; Chapman RM; Thomas PW; Copplestone JA; Orchard JA; Hamblin TJ
Blood; 2002 Aug; 100(4):1177-84. PubMed ID: 12149195
[TBL] [Abstract][Full Text] [Related]
19. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
[TBL] [Abstract][Full Text] [Related]
20. Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH.
Mian M; Rinaldi A; Mensah AA; Rossi D; Ladetto M; Forconi F; Marasca R; Uhr M; Stussi G; Kwee I; Cavalli F; Gaidano G; Zucca E; Bertoni F
Ann Oncol; 2013 May; 24(5):1378-84. PubMed ID: 23372049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
